|
|
|
|
|
|
|
|
Topic 1—
|
Defining the rationale and role for targeted therapy in ovarian cancer
Nicoletta Colombo, MD |
Topic 2—
|
Targeting angiogenesis: Where are we in 2010?
Robert A. Burger, MD, FACOG, FACS |
Topic 3—
|
Beyond antiangiogenesis: What are the options?
Andres Poveda, MD
This Webcast contains video and downloadable slides from our symposium “Evolving Strategies in the Management of Advanced Ovarian Cancer,” a prIME Oncology educational activity that was held after the official ESMO program hours on Monday, 11 October in Milan, Italy.
|
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.